Lara Maxwell
Overview
Explore the profile of Lara Maxwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shea B, Pardo J, Grosskleg S, Beaton D, Conaghan P, Goettsch W, et al.
Semin Arthritis Rheum
. 2024 Mar;
66:152438.
PMID: 38555726
Objective: This manuscript highlights the importance of enhancing the uptake of Core Outcome Sets (COS) by building partnerships with Collaborators and addressing their needs in COS development. Methods And Setting:...
2.
Karunananthan S, Grimshaw J, Maxwell L, Nguyen P, Page M, Pardo J, et al.
BMJ Evid Based Med
. 2023 Oct;
29(5):285-288.
PMID: 37821212
No abstract available.
3.
Leung J, Twohig H, Muller S, Maxwell L, Mackie S, Neill L, et al.
Semin Arthritis Rheum
. 2023 Jul;
62:152239.
PMID: 37429139
Objective: To examine the test-retest reliability of four measurement instruments in polymyalgia rheumatica (PMR): pain severity visual analogue scale (VAS) / numerical rating score (NRS), stiffness severity VAS/NRS, the Health...
4.
Maxwell L, McCarrel T, Hay S, Cole C
J Vet Pharmacol Ther
. 2023 Mar;
46(4):250-256.
PMID: 36994984
The antifibrinolytic agent aminocaproic acid (ACA) is occasionally used prior to episodes of intense training in racehorses suffering from exercise-induced pulmonary hemorrhage. Although a previous study indicated that the drug...
5.
DiRenzo D, Saygin D, de Groot I, Bingham III C, Lundberg I, Needham M, et al.
Semin Arthritis Rheum
. 2022 Nov;
58:152111.
PMID: 36410180
Objective: Pain interference, fatigue, and impaired physical function are common features of idiopathic inflammatory myopathies (IIM). The objective of this study was to evaluate the construct validity and test-retest reliability...
6.
Janusz N, Dewidar O, Dowling S, Wang H, Buchbinder R, Conde M, et al.
J Rheumatol
. 2022 Aug;
49(12):1379-1384.
PMID: 35970529
Objective: To evaluate the extent to which Cochrane Musculoskeletal systematic reviews assess and analyze health equity considerations. Methods: We included Cochrane Musculoskeletal systematic reviews that included trials with participants aged...
7.
Williams M, Holbrook T, Maxwell L, Croft C, Ientile M, Cliburn K
J Equine Vet Sci
. 2021 Dec;
110:103842.
PMID: 34923070
Cannabidiol (CBD) products have gained popularity among horse owners despite limited evidence regarding pharmacokinetics. The purpose of this study was to describe the pharmacokinetic profile of multiple doses of an...
8.
Petkovic J, Umaefulam V, Wattiaux A, Bartels C, Barnabe C, Greer-Smith R, et al.
Semin Arthritis Rheum
. 2021 Oct;
51(6):1300-1310.
PMID: 34625296
Objective: To develop an equity extension of the OMERACT Summary of Measurement Properties (SOMP) Table, SOMP Equity to describe whether a patient reported outcome measure (PROM) works well among patients...
9.
Roofeh D, Barratt S, Wells A, Kawano-Dourado L, Tashkin D, Strand V, et al.
Semin Arthritis Rheum
. 2021 Sep;
51(6):1331-1341.
PMID: 34493396
Objective: The Outcome Measures in Rheumatology (OMERACT) is a research organization focused on improving health care outcomes for patients with autoimmune and musculoskeletal diseases. The Connective Tissue Disease-Interstitial Lung Disease...
10.
Grosskleg S, Beaton D, Conaghan P, Hofstetter C, Maxwell L, Shea B, et al.
Semin Arthritis Rheum
. 2021 May;
51(3):588-592.
PMID: 33941384
No abstract available.